Dr. Takenaka moved to Canada in 2000 for postdoctoral research in Dr. John Dick’s laboratory at the Ontario Cancer Institute in Toronto. There, he advanced the understanding of immunodeficient mouse models for human leukemia stem cell assays and the molecular basis of leukemia stem cells. He returned to Japan in 2005 as an Associate Professor […]
Prof. Tong has over 30 years of experience in the field of malignant myeloid tumors, especially myelodysplastic syndromes (MDS), with a focus on precise diagnosis and novel strategies for the prevention and treatment of MDS. Her laboratory has contributed to breakthrough therapies involving hypomethylating agents in MDS. She has published over 60 peer-reviewed articles in […]
Dr. Verstovsek was Professor of Medicine and hematologist-oncologist at MD Anderson Cancer Center in Houston, Texas. He is a global leader in myeloproliferative neoplasms (MPN) and the Founder/Director of the largest single institution MPN Clinical Research Center worldwide. Dr. Verstovsek has achieved international acclaim for his leadership in developing landmark MPN therapeutics and have received […]
Dr. Wong received his Bachelor of Medicine and Bachelor of Surgery from the Chinese University of Hong Kong and completed specialist training in Haematology & Haematological Oncology, Internal Medicine, and Clinical Pharmacology and Therapeutics at Prince of Wales Hospital, Hong Kong. He further undertook Blood and Marrow Transplantation Fellowship training at MD Anderson Cancer Center, […]
Dr. Zhang is a leading researcher at the Shanghai Institute of Hematology. He holds key roles in hematology organizations, including Deputy Chief of the Leukemia and Lymphoma Group of the Chinese Society of Hematology and Vice Chairman of the Anti-Leukemia Union of the Chinese Society of Clinical Oncology. Dr. Zhang’s research expertise includes hematologic malignancies, particularly […]
Dr. Dong-Tsamn Lin graduated from the College of Medicine at National Taiwan University in 1974 and completed a three-year pediatric residency at National Taiwan University Hospital. After serving as chief resident, he joined the same institution as a visiting staff member and teaching faculty in pediatric hematology/oncology, and in 1979 assumed responsibility for the hospital […]
Dr. Ng Chin Hin is a Senior Consultant Haematologist who specialises in Leukaemia and other blood cancers. He was the Leukaemia Lead at National University Cancer Institute of Singapore (NCIS) and has more than 10 years experience in this field. He was active in clinical research and was the Research Director for the Haematology Division […]
Dr. Shih is the program director of Section of Hematology of CGMH and she leads the Taiwan Chronic Myeloid Leukemia Study Group and Myeloproliferative Neoplasms Working Group. She is a member of International Working Group for Prognosis in Myelodysplastic Syndromes (IWG-PM) Molecular Project and the representative of Taiwan for MPN of EHA-SWG. Her research interests […]
Dr. Choi is a recognized leader in myeloproliferative neoplasms (MPNs), with extensive clinical and research experience in hematologic malignancies. He earned his M.D. and Ph.D. from Korea University and completed his clinical training at Korea University Medical Center, where he has since built his academic career. He currently serves as Professor and Chief of the Division […]
Dr. Chou obtained medical degree from National Taiwan University College of Medicine in 1990 and received training in general internal medicine, hematology, and medical oncology at National Taiwan University Hospital. Dr. Chou later received Ph.D. training in Human Genetics Program at Johns Hopkins University from 1998 to 2003. He also did his postdoctoral fellowship in […]